Table 3:

Multivariable analysis of model A for recurrence-free survival in lung adenocarcinoma patients (n = 139)

VariableMultivariable analysis
Hazard ratio95% CIP-value
CEA>5.03.441.39–8.470.007
SUVmax>3.458.562.53–28.90.001
VariableMultivariable analysis
Hazard ratio95% CIP-value
CEA>5.03.441.39–8.470.007
SUVmax>3.458.562.53–28.90.001

CEA, carcinoembryonic antigen; CI: confidence interval; SUVmax, maximum standardized uptake value.

Table 3:

Multivariable analysis of model A for recurrence-free survival in lung adenocarcinoma patients (n = 139)

VariableMultivariable analysis
Hazard ratio95% CIP-value
CEA>5.03.441.39–8.470.007
SUVmax>3.458.562.53–28.90.001
VariableMultivariable analysis
Hazard ratio95% CIP-value
CEA>5.03.441.39–8.470.007
SUVmax>3.458.562.53–28.90.001

CEA, carcinoembryonic antigen; CI: confidence interval; SUVmax, maximum standardized uptake value.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close